News
For Sarepta, the hits keep coming, with several downgrades in the past week after it was forced to temporarily take its ...
The Food and Drug Administration won’t sign off on Sarepta Therapeutics Inc. bringing its controversial gene therapy back to ...
The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...
Kratom affects the same receptors in the brain as opioids, meaning that in high doses, it can produce similar euphoric and ...
Learn how ATTR-CM is treated with medications that slow down the condition's progression and other therapies that reduce symptoms and improve the quality of life.
BioPoly, an orthopedic startup based in Fort Wayne, is approaching the start of an FDA-approved clinical trial of a knee ...
The controversial drugs are not yet approved by federal regulators, but advocates hope a NC law would allow the state to be ...
The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug Evaluation and Research (CDER).
The FDA is taking steps to ban current prescriptions.
Missouri's Republican attorney general filed a lawsuit on Wednesday accusing reproductive healthcare provider Planned ...
D r. James H. Bekker made it clear while standing at a podium in front of the U.S. Food and Drug Administration (FDA) in ...
U.S. Food and Drug Administration Commissioner Marty Makary said he is focused on overhauling long-held standards and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results